Why Centralize Spirometry Data?

Tuesday, March 5 2013
11:00 am

Location: Live webcast

As the primary and secondary end points in a majority of pulmonary clinical trials, obtaining high quality pulmonary function data is of paramount importance. While variability is inherent in such 
effort dependent testing, engaging the centralization and professional review services of an  experienced clinical trial service provider can increase reproducibility and quality of data captured creating cost efficiencies. 

Learning Objectives:

  • How centralized spirometry can improve clinical data
  • Reducing study costs by centralizing data
  • Quality issues impacting spirometry data
  • International guidelines for quality
  • Challenges in centralized spirometry trials

Scott Burcham, RRT Executive Director, Pulmonary Services Biomedical Systems
Mr. Burcham has served as Biomedical Systems’ Executive Director of Pulmonary Services since  1994 and brings over 16 years of clinical trial expertise in addition to 30 years of experience as a  Registered Respiratory Therapist. As an expert in the centralization of pulmonary function data, he  has been instrumental in developing many products available for centralizing and processing  pulmonary function data in clinical trials. Mr. Burcham is an active member of the American  Thoracic Society (ATS), European Respiratory Society (ERS), and the American Association for  Respiratory Care (AARC). 

Share MassBio